Dr. Min Seob Lee is co-chairman of the board of Diagnomics and a co-founder. He is on the scientific advisory board of the Personal Genomics Institute (PGI) and has extensive experience in the biotech industry. He worked in diagnostics and therapeutic settings, with specific expertise in genomics, pharmacogenomics, bioinformatics and diagnostic development. He is a world leader in genomics, diagnostics and associated applications for personalized medicine. Prior to Diagnomics, he was a vice president of the Theragen Bio Institute and CTO of GenomeCare and Precision Biocount. He also held several positions of increasing responsibility at Sequenom in Molecular Medicine and Diagnostic Development. Dr. Lee also served as a Senior Manager in CLIA and GLP laboratories performing high-throughput genome sequencing and genotyping at Genaissance Pharmaceuticals in Connecticut.
Dr. Lee published numerous articles and has been granted several important genomics and molecular diagnostics patents. He conducted his post-doctoral fellowship at Harvard Medical School, and received a Ph.D. from the City of Hope National Medical Center and Beckman Research Institute in California.